Dr Paul Griffin
Director of Infectious Diseases
Mater Health Services
QUEENSLAND, AUSTRALIA
Watch Dr Paul Griffin talk about research and clinical trials in over 150 infectious disease vaccines for COVID-19, influenza, RSV and others.
You Might also like
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
Dr Jade Murray
DR JADE MURRAY, POSTDOCTORAL RESEARCH FELLOW
TURNER INSTITUTE FOR BRAIN AND MENTAL HEALTH, MONASH UNIVERSITY
VICTORIA, AUSTRALIA -
Professor Ramon Shaban
PROFESSOR RAMON SHABAN, CLINICAL CHAIR
COMMUNICABLE DISEASE CONTROL AND INFECTION PREVENTION
WESTERN HEALTH PRECINCT, SYDNEY, AUSTRALIA